Cranbrook Wealth Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $21.9K | Hold |
|
|||||
|
2025
Q2 | $19.5K | Hold |
|
|||||
|
2025
Q1 | $19.7K | Hold |
|
|||||
|
2024
Q4 | $17.2K | Hold |
|
|||||
|
2024
Q3 | $20.8K | Hold |
|
|||||
|
2024
Q2 | $19.6K | Hold |
|
|||||
|
2024
Q1 | $21.8K | Hold |
|
|||||
|
2023
Q4 | $18.8K | Hold |
|
|||||
|
2023
Q3 | $18.4K | Hold |
|
|||||
|
2023
Q2 | $18.1K | Hold |
|
|||||
|
2023
Q1 | $18.1K | Hold |
|
|||||
|
2022
Q4 | $17.9K | Hold |
|
|||||
|
2022
Q3 | $15K | Sell |
|
|||||
|
2022
Q2 | $28K | Hold |
|
|||||
|
2022
Q1 | $28K | Hold |
|
|||||
|
2021
Q4 | $28K | Hold |
|
|||||
|
2021
Q3 | $24K | Hold |
|
|||||
|
2021
Q2 | $25K | Hold |
|
|||||
|
2021
Q1 | $23K | Hold |
|
|||||
|
2020
Q4 | $23K | Hold |
|
|||||
|
2020
Q3 | $24K | Hold |
|
|||||
|
2020
Q2 | $26K | Hold |
|
|||||
|
2020
Q1 | $24K | Hold |
|
|||||
|
2019
Q4 | $30K | Hold |
|
|||||
|
2019
Q3 | $27K | Hold |
|
|||||
|
2019
Q2 | $25K | Hold |
|
|||||
|
2019
Q1 | $27K | Hold |
|
|||||
|
2018
Q4 | $24K | Hold |
|
|||||
|
2018
Q3 | $26K | Hold |
|
|||||
|
2018
Q2 | $26K | Hold |
|
|||||
|
2018
Q1 | $25K | Hold |
|
|||||
|
2017
Q4 | $23K | Hold |
|
|||||
|
2017
Q3 | $26K | Hold |
|
|||||
|
2017
Q2 | $27K | Hold |
|
|||||
|
2017
Q1 | $27K | Hold |
|
|||||
|
2016
Q4 | $24K | Hold |
|
|||||
|
2016
Q3 | $27K | Hold |
|
|||||
|
2016
Q2 | $28K | Hold |
|
|||||
|
2016
Q1 | $26K | Hold |
|
|||||
|
2015
Q4 | $26K | Hold |
|
|||||
|
2015
Q3 | $24K | Hold |
|
|||||
|
2015
Q2 | $26K | Hold |
|
|||||
|
2015
Q1 | $29K | Hold |
|
|||||
|
2014
Q4 | $27K | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $68K | Buy |
|